Immune Checkpoint Inhibitor‐Based Strategies for Synergistic Cancer Therapy

Construction of a core-shell microneedle system to achieve targeted co-delivery of checkpoint inhibitors for melanoma immunotherapy

(2020) Peipei Yang et al.   Acta Biomaterialia

Possibilities of Improving the Clinical Value of Immune Checkpoint Inhibitor Therapies in Cancer Care by Optimizing Patient Selection

(2020) Sanna Iivanainen et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Modularly Designed Peptide Nanoprodrug Augments Antitumor Immunity of PD-L1 Checkpoint Blockade by Targeting Indoleamine 2,3-Dioxygenase

(2020) Xuexiang Han et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

Intratumoral expression of IL-7 and IL-12 using an oncolytic virus increases systemic sensitivity to immune checkpoint blockade

(2020) Shinsuke Nakao et al.   Science Translational Medicine

Construction of microneedle-assisted co-delivery platform and its combining photodynamic/immunotherapy

(2020) Shi-Xiong Chen et al.   JOURNAL OF CONTROLLED RELEASE

Delivery technologies for cancer immunotherapy

(2019) Rachel S. Riley et al.   NATURE REVIEWS DRUG DISCOVERY

State of clinical research of radiotherapy/chemoradiotherapy and immune checkpoint inhibitor therapy combinations in solid tumours—a German radiation oncology survey

(2019) Lukas Käsmann et al.   EUROPEAN JOURNAL OF CANCER

Hypoxia alleviation-triggered enhanced photodynamic therapy in combination with IDO inhibitor for preferable cancer therapy

(2019) Lei Xing et al.   BIOMATERIALS

Surface Functionalized Modified Copper Sulfide Nanoparticles Enhance Checkpoint Blockade Tumor Immunotherapy by Photothermal Therapy and Antigen-Capturing

(2019) Ruoping Wang et al.   ACS Applied Materials & Interfaces

Biohybrid Vaccines for Improved Treatment of Aggressive Melanoma with Checkpoint Inhibitor

(2019) Flavia Fontana et al.   ACS Nano

Hyaluronidase with pH‐responsive Dextran Modification as an Adjuvant Nanomedicine for Enhanced Photodynamic‐Immunotherapy of Cancer

(2019) Hairong Wang et al.   ADVANCED FUNCTIONAL MATERIALS

Overview of recent advances in liposomal nanoparticle-based cancer immunotherapy

(2019) Ang Gao et al.   ACTA PHARMACOLOGICA SINICA

Tumor Microenvironment‐Responsive Dual Drug Dimer‐Loaded PEGylated Bilirubin Nanoparticles for Improved Drug Delivery and Enhanced Immune‐Chemotherapy of Breast Cancer

(2019) Xiaotong Yang et al.   ADVANCED FUNCTIONAL MATERIALS

Emerging strategies in cancer therapy combining chemotherapy with immunotherapy

(2019) Qiuhua Luo et al.   CANCER LETTERS

Phototherapy using immunologically modified carbon nanotubes to potentiate checkpoint blockade for metastatic breast cancer

(2019) Yong Li et al.   Nanomedicine-Nanotechnology Biology and Medicine

Immune checkpoints in the tumor microenvironment

(2019) Salman M. Toor et al.   SEMINARS IN CANCER BIOLOGY

Self‐Amplified Drug Delivery with Light‐Inducible Nanocargoes to Enhance Cancer Immunotherapy

(2019) Bing Feng et al.   ADVANCED MATERIALS

Activating Antitumor Immunity and Antimetastatic Effect Through Polydopamine‐Encapsulated Core–Shell Upconversion Nanoparticles

(2019) Shuangqian Yan et al.   ADVANCED MATERIALS

First-line PD-1/PD-L1 inhibitor plus chemotherapy vs chemotherapy alone for negative or 

(2019) Thierry Landre et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

The landscape of immune checkpoint inhibitor plus chemotherapy versus immunotherapy for advanced non‐small‐cell lung cancer: A systematic review and meta‐analysis

(2019) Chengdi Wang et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Sheddable Prodrug Vesicles Combating Adaptive Immune Resistance for Improved Photodynamic Immunotherapy of Cancer

(2019) Ang Gao et al.   NANO LETTERS

A Cisplatin-Loaded Immunochemotherapeutic Nanohybrid Bearing Immune Checkpoint Inhibitors for Enhanced Cervical Cancer Therapy

(2018) Na Wang et al.   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

Innovative Strategies for Hypoxic-Tumor Photodynamic Therapy

(2018) Xingshu Li et al.   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

Nanoparticle-Based Phototriggered Cancer Immunotherapy and Its Domino Effect in the Tumor Microenvironment

(2018) Santhosh Kalash Rajendrakumar et al.   BIOMACROMOLECULES

Emerging Concepts for Immune Checkpoint Blockade-Based Combination Therapies

(2018) Roberta Zappasodi et al.   CANCER CELL

A patent review of IDO1 inhibitors for cancer

(2018) Jae Eun Cheong et al.   EXPERT OPINION ON THERAPEUTIC PATENTS

The efficacy and safety of anti-PD-1/PD-L1 antibodies combined with chemotherapy or CTLA4 antibody as a first-line treatment for advanced lung cancer

(2018) Xiaoling Xu et al.   INTERNATIONAL JOURNAL OF CANCER

Nanoscale Metal–Organic Framework Overcomes Hypoxia for Photodynamic Therapy Primed Cancer Immunotherapy

(2018) Guangxu Lan et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

Increased Response Rates to Salvage Chemotherapy Administered after PD-1/PD-L1 Inhibitors in Patients with Non–Small Cell Lung Cancer

(2018) Song Ee Park et al.   Journal of Thoracic Oncology

Synergy of Immune Checkpoint Blockade with a Novel Synthetic Consensus DNA Vaccine Targeting TERT

(2018) Elizabeth K. Duperret et al.   MOLECULAR THERAPY

PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell Carcinoma

(2018) Michael R. Migden et al.   NEW ENGLAND JOURNAL OF MEDICINE

Combining chemotherapy with PD-1 blockade in NSCLC

(2018) Matthen Mathew et al.   PHARMACOLOGY & THERAPEUTICS

CHECKPOINT INHIBITOR IMMUNE THERAPY

(2018) Lauren A. Dalvin et al.   RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES

Cancer immunotherapy using checkpoint blockade

(2018) Antoni Ribas et al.   SCIENCE

Neoadjuvant oncolytic virotherapy before surgery sensitizes triple-negative breast cancer to immune checkpoint therapy

(2018) Marie-Claude Bourgeois-Daigneault et al.   Science Translational Medicine

Intravenous delivery of oncolytic reovirus to brain tumor patients immunologically primes for subsequent checkpoint blockade

(2018) Adel Samson et al.   Science Translational Medicine

In situ formed reactive oxygen species–responsive scaffold with gemcitabine and checkpoint inhibitor for combination therapy

(2018) Chao Wang et al.   Science Translational Medicine

Synergistic and low adverse effect cancer immunotherapy by immunogenic chemotherapy and locally expressed PD-L1 trap

(2018) Wantong Song et al.   Nature Communications

Robust Antitumor Responses Result from Local Chemotherapy and CTLA-4 Blockade

(2018) Charlotte E. Ariyan et al.   Cancer Immunology Research

Photosensitizer Micelles Together with IDO Inhibitor Enhance Cancer Photothermal Therapy and Immunotherapy

(2018) Jinrong Peng et al.   Advanced Science

Heating it up: Oncolytic viruses make tumors ‘hot’ and suitable for checkpoint blockade immunotherapies

(2018) Shashi Gujar et al.   OncoImmunology

Low-dose X-ray radiotherapy–radiodynamic therapy via nanoscale metal–organic frameworks enhances checkpoint blockade immunotherapy

(2018) Kuangda Lu et al.   Nature Biomedical Engineering

Combined local immunostimulatory radioisotope therapy and systemic immune checkpoint blockade imparts potent antitumour responses

(2018) Yu Chao et al.   Nature Biomedical Engineering

Binary Cooperative Prodrug Nanoparticles Improve Immunotherapy by Synergistically Modulating Immune Tumor Microenvironment

(2018) Bing Feng et al.   ADVANCED MATERIALS

Tip-loaded fast-dissolving microneedle patches for photodynamic therapy of subcutaneous tumor

(2018) Xiao Zhao et al.   JOURNAL OF CONTROLLED RELEASE

Neurologische Nebenwirkungen von Checkpoint-Inhibitoren

(2018) S. Knauss et al.   NERVENARZT

Hyperprogressive Disease in Patients With Advanced Non–Small Cell Lung Cancer Treated With PD-1/PD-L1 Inhibitors or With Single-Agent Chemotherapy

(2018) Roberto Ferrara et al.   JAMA Oncology

Nanoscale Reduced Graphene Oxide-Mediated Photothermal Therapy Together with IDO Inhibition and PD-L1 Blockade Synergistically Promote Antitumor Immunity

(2018) Mengmeng Yan et al.   ACS Applied Materials & Interfaces

Breast Cancer Chemo-immunotherapy through Liposomal Delivery of an Immunogenic Cell Death Stimulus Plus Interference in the IDO-1 Pathway

(2018) Jianqin Lu et al.   ACS Nano

Microneedle-Assisted Topical Delivery of Photodynamically Active Mesoporous Formulation for Combination Therapy of Deep-Seated Melanoma

(2018) Huijun Phoebe Tham et al.   ACS Nano

Myositis and neuromuscular side-effects induced by immune checkpoint inhibitors

(2018) Alvaro Moreira et al.   EUROPEAN JOURNAL OF CANCER

Intradermal delivery of vaccine nanoparticles using hollow microneedle array generates enhanced and balanced immune response

(2018) Lin Niu et al.   JOURNAL OF CONTROLLED RELEASE

Cancer immunoediting and resistance to T cell-based immunotherapy

(2018) Jake S. O’Donnell et al.   Nature Reviews Clinical Oncology

Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer

(2018) Peter Schmid et al.   NEW ENGLAND JOURNAL OF MEDICINE

Endocrine side effects of cancer immunotherapy

(2017) Priscilla Cukier et al.   ENDOCRINE-RELATED CANCER

PD-1 checkpoint blockade alone or combined PD-1 and CTLA-4 blockade as immunotherapy for lung cancer?

(2017) Tawee Tanvetyanon et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Introduction to checkpoint inhibitors and cancer immunotherapy

(2017) Arlene H. Sharpe   IMMUNOLOGICAL REVIEWS

Novel dissolving microneedles for enhanced transdermal delivery of levonorgestrel: In vitro and in vivo characterization

(2017) Gangtao Yao et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Clinical Advances of Hypoxia-Activated Prodrugs in Combination With Radiation Therapy

(2017) Ishna N. Mistry et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Avelumab, an Anti–Programmed Death-Ligand 1 Antibody, In Patients With Refractory Metastatic Urothelial Carcinoma: Results From a Multicenter, Phase Ib Study

(2017) Andrea B. Apolo et al.   JOURNAL OF CLINICAL ONCOLOGY

Prussian blue nanoparticle-based photothermal therapy combined with checkpoint inhibition for photothermal immunotherapy of neuroblastoma

(2017) Juliana Cano-Mejia et al.   Nanomedicine-Nanotechnology Biology and Medicine

A combination of nanosystems for the delivery of cancer chemoimmunotherapeutic combinations: 1-Methyltryptophan nanocrystals and paclitaxel nanoparticles

(2017) P. Calleja et al.   PHARMACOLOGICAL RESEARCH

Matrix-binding checkpoint immunotherapies enhance antitumor efficacy and reduce adverse events

(2017) Jun Ishihara et al.   Science Translational Medicine

Integrating Next-Generation Dendritic Cell Vaccines into the Current Cancer Immunotherapy Landscape

(2017) Abhishek D. Garg et al.   TRENDS IN IMMUNOLOGY

Immune checkpoint inhibitor colitis: the flip side of the wonder drugs

(2017) Naziheh Assarzadegan et al.   VIRCHOWS ARCHIV

Hollow MnO2 as a tumor-microenvironment-responsive biodegradable nano-platform for combination therapy favoring antitumor immune responses

(2017) Guangbao Yang et al.   Nature Communications

Enhanced antitumor effects by combining an IL-12/anti-DNA fusion protein with avelumab, an anti-PD-L1 antibody

(2017) Jonathan K. Fallon et al.   Oncotarget

Photodynamic-Immune Checkpoint Therapy Eradicates Local and Distant Tumors by CD8 + T Cells

(2017) Jan Willem Kleinovink et al.   Cancer Immunology Research

CCL3 augments tumor rejection and enhances CD8+ T cell infiltration through NK and CD103+ dendritic cell recruitment via IFNγ

(2017) Frederick Allen et al.   OncoImmunology

Modulation of the Intratumoral Immune Landscape by Oncolytic Herpes Simplex Virus Virotherapy

(2017) Jie Yin et al.   Frontiers in Oncology

Designing nanomedicine for immuno-oncology

(2017) Wen Jiang et al.   Nature Biomedical Engineering

Ror2 signaling regulates Golgi structure and transport through IFT20 for tumor invasiveness

(2017) Michiru Nishita et al.   Scientific Reports

Synergistic Immuno Photothermal Nanotherapy (SYMPHONY) for the Treatment of Unresectable and Metastatic Cancers

(2017) Yang Liu et al.   Scientific Reports

Synergistic Transcutaneous Immunotherapy Enhances Antitumor Immune Responses through Delivery of Checkpoint Inhibitors

(2016) Yanqi Ye et al.   ACS Nano

Coinhibitory Pathways in Immunotherapy for Cancer

(2016) Susanne H. Baumeister et al.   Annual Review of Immunology

Ipilimumab with Stereotactic Ablative Radiation Therapy: Phase I Results and Immunologic Correlates from Peripheral T Cells

(2016) Chad Tang et al.   CLINICAL CANCER RESEARCH

Immune checkpoint inhibitor-related hypophysitis and endocrine dysfunction: clinical review

(2016) M.N Joshi et al.   CLINICAL ENDOCRINOLOGY

PD‐L1 blockade enhances response of pancreatic ductal adenocarcinoma to radiotherapy

(2016) Abul Azad et al.   EMBO Molecular Medicine

IL-6 and PD-L1 antibody blockade combination therapy reduces tumour progression in murine models of pancreatic cancer

(2016) Thomas A Mace et al.   GUT

Lag-3, Tim-3, and TIGIT: Co-inhibitory Receptors with Specialized Functions in Immune Regulation

(2016) Ana C. Anderson et al.   IMMUNITY

Immunogenic Chemotherapy Sensitizes Tumors to Checkpoint Blockade Therapy

(2016) Christina Pfirschke et al.   IMMUNITY

Atezolizumab, an Anti–Programmed Death-Ligand 1 Antibody, in Metastatic Renal Cell Carcinoma: Long-Term Safety, Clinical Activity, and Immune Correlates From a Phase Ia Study

(2016) David F. McDermott et al.   JOURNAL OF CLINICAL ONCOLOGY

Safety and Efficacy of Durvalumab (MEDI4736), an Anti–Programmed Cell Death Ligand-1 Immune Checkpoint Inhibitor, in Patients With Advanced Urothelial Bladder Cancer

(2016) Christophe Massard et al.   JOURNAL OF CLINICAL ONCOLOGY

Photodynamic Therapy Mediated by Nontoxic Core–Shell Nanoparticles Synergizes with Immune Checkpoint Blockade To Elicit Antitumor Immunity and Antimetastatic Effect on Breast Cancer

(2016) Xiaopin Duan et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

Combination Therapy With Reovirus and Anti-PD-1 Blockade Controls Tumor Growth Through Innate and Adaptive Immune Responses

(2016) Karishma Rajani et al.   MOLECULAR THERAPY

Acid-Activatable Versatile Micelleplexes for PD-L1 Blockade-Enhanced Cancer Photodynamic Immunotherapy

(2016) Dangge Wang et al.   NANO LETTERS

Designer vaccine nanodiscs for personalized cancer immunotherapy

(2016) Rui Kuai et al.   NATURE MATERIALS

The future of cancer treatment: immunomodulation, CARs and combination immunotherapy

(2016) Danny N. Khalil et al.   Nature Reviews Clinical Oncology

PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations

(2016) Weiping Zou et al.   Science Translational Medicine

An immunostimulatory dual-functional nanocarrier that improves cancer immunochemotherapy

(2016) Yichao Chen et al.   Nature Communications

Core-shell nanoscale coordination polymers combine chemotherapy and photodynamic therapy to potentiate checkpoint blockade cancer immunotherapy

(2016) Chunbai He et al.   Nature Communications

Temperature-feedback upconversion nanocomposite for accurate photothermal therapy at facile temperature

(2016) Xingjun Zhu et al.   Nature Communications

Is there a role for therapeutic cancer vaccines in the age of checkpoint inhibitors?

(2016) Robert O. Dillman   Human Vaccines & Immunotherapeutics

Optimizing Timing of Immunotherapy Improves Control of Tumors by Hypofractionated Radiation Therapy

(2016) Kristina H. Young et al.   PLoS One

Polydopamine as a Biocompatible Multifunctional Nanocarrier for Combined Radioisotope Therapy and Chemotherapy of Cancer

(2015) Xiaoyan Zhong et al.   ADVANCED FUNCTIONAL MATERIALS

Immunological Effects of Conventional Chemotherapy and Targeted Anticancer Agents

(2015) Lorenzo Galluzzi et al.   CANCER CELL

Immune-modulating properties of ionizing radiation: rationale for the treatment of cancer by combination radiotherapy and immune checkpoint inhibitors

(2015) Anja Derer et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Abscopal effects of radiation therapy: A clinical review for the radiobiologist

(2015) Shankar Siva et al.   CANCER LETTERS

Recent developments and future challenges in immune checkpoint inhibitory cancer treatment

(2015) Bas D. Koster et al.   CURRENT OPINION IN ONCOLOGY

PD-1/PD-L1 inhibitors

(2015) Joel Sunshine et al.   CURRENT OPINION IN PHARMACOLOGY

Investigation on fabrication process of dissolving microneedle arrays to improve effective needle drug distribution

(2015) Qingqing Wang et al.   EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

Combinatorial cancer immunotherapy strategies with proapoptotic small-molecule IAP antagonists

(2015) Shawn T. Beug et al.   INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY

Nivolumab for Metastatic Renal Cell Carcinoma: Results of a Randomized Phase II Trial

(2015) Robert J. Motzer et al.   JOURNAL OF CLINICAL ONCOLOGY

A Pt(IV) Pro-drug Preferentially Targets Indoleamine-2,3-dioxygenase, Providing Enhanced Ovarian Cancer Immuno-Chemotherapy

(2015) Samuel G. Awuah et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

Nanoscintillator-Mediated X-ray Inducible Photodynamic Therapy for In Vivo Cancer Treatment

(2015) Hongmin Chen et al.   NANO LETTERS

Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer

(2015) Edward B. Garon et al.   NEW ENGLAND JOURNAL OF MEDICINE

Pembrolizumab versus Ipilimumab in Advanced Melanoma

(2015) Caroline Robert et al.   NEW ENGLAND JOURNAL OF MEDICINE

T cell exclusion, immune privilege, and the tumor microenvironment

(2015) J. A. Joyce et al.   SCIENCE

Human cancer immunotherapy with antibodies to the PD-1 and PD-L1 pathway

(2015) Kim C. Ohaegbulam et al.   TRENDS IN MOLECULAR MEDICINE

Checkpoint blockade for cancer therapy: revitalizing a suppressed immune system

(2015) Yago Pico de Coaña et al.   TRENDS IN MOLECULAR MEDICINE

Vaccines Combined with Immune Checkpoint Antibodies Promote Cytotoxic T-cell Activity and Tumor Eradication

(2015) O. A. Ali et al.   Cancer Immunology Research

Salvage photodynamic therapy for recurrent nasopharyngeal carcinoma

(2014) Giovanni Succo et al.   Photodiagnosis and Photodynamic Therapy

Kinomic exploration of temozolomide and radiation resistance in Glioblastoma multiforme xenolines

(2014) Joshua C. Anderson et al.   RADIOTHERAPY AND ONCOLOGY

Bioinspired polydopamine nanospheres: a superquencher for fluorescence sensing of biomolecules

(2014) Weibing Qiang et al.   Chemical Science

Dual Blockade of PD-1 and CTLA-4 Combined with Tumor Vaccine Effectively Restores T-Cell Rejection Function in Tumors

(2013) J. Duraiswamy et al.   CANCER RESEARCH

Molecular Pathways: Coexpression of Immune Checkpoint Molecules: Signaling Pathways and Implications for Cancer Immunotherapy

(2013) C. J. Nirschl et al.   CLINICAL CANCER RESEARCH

Combining Radiotherapy and Cancer Immunotherapy: A Paradigm Shift

(2013) Silvia C. Formenti et al.   JNCI-Journal of the National Cancer Institute

Cancer Immunotherapy

(2013) J. Couzin-Frankel   SCIENCE

Microneedles for drug and vaccine delivery

(2012) Yeu-Chun Kim et al.   ADVANCED DRUG DELIVERY REVIEWS

The Biology of Recent Thymic Emigrants

(2012) Pamela J. Fink   Annual Review of Immunology

Nanomaterials for targeted detection and photothermal killing of bacteria

(2012) Paresh Chandra Ray et al.   CHEMICAL SOCIETY REVIEWS

IL-17/IL-17 receptor system in autoimmune disease: mechanisms and therapeutic potential

(2012) Shu Zhu et al.   CLINICAL SCIENCE

Image-guided radiotherapy: from current concept to future perspectives

(2012) David A. Jaffray   Nature Reviews Clinical Oncology

Immunologic Correlates of the Abscopal Effect in a Patient with Melanoma

(2012) Michael A. Postow et al.   NEW ENGLAND JOURNAL OF MEDICINE

Fabrication of Silk Microneedles for Controlled-Release Drug Delivery

(2011) Konstantinos Tsioris et al.   ADVANCED FUNCTIONAL MATERIALS

Hallmarks of Cancer: The Next Generation

(2011) Douglas Hanahan et al.   CELL

Cutting Edge: TIGIT Has T Cell-Intrinsic Inhibitory Functions

(2011) N. Joller et al.   JOURNAL OF IMMUNOLOGY

Cancer immunotherapy – revisited

(2011) W. Joost Lesterhuis et al.   NATURE REVIEWS DRUG DISCOVERY

The Indoleamine-2,3-Dioxygenase (IDO) Inhibitor 1-Methyl-D-tryptophan Upregulates IDO1 in Human Cancer Cells

(2011) Christiane A. Opitz et al.   PLoS One

Natural and genetically engineered proteins for tissue engineering

(2011) Sílvia Gomes et al.   PROGRESS IN POLYMER SCIENCE

Photodynamic therapy: illuminating the road from cell death towards anti-tumour immunity

(2010) Abhishek D. Garg et al.   APOPTOSIS

Imaging and Photodynamic Therapy: Mechanisms, Monitoring, and Optimization

(2010) Jonathan P. Celli et al.   CHEMICAL REVIEWS

Stimulation of anti-tumor immunity by photodynamic therapy

(2010) Pawel Mroz et al.   Expert Review of Clinical Immunology

IAP inhibitors enhance co-stimulation to promote tumor immunity

(2010) Michael Dougan et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Dissolving polymer microneedle patches for influenza vaccination

(2010) Sean P Sullivan et al.   NATURE MEDICINE

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

(2010) F. Stephen Hodi et al.   NEW ENGLAND JOURNAL OF MEDICINE

A New Era for Cancer Treatment: Gold-Nanoparticle-Mediated Thermal Therapies

(2010) Laura C. Kennedy et al.   Small

Kynurenic Acid Is a Potent Endogenous Aryl Hydrocarbon Receptor Ligand that Synergistically Induces Interleukin-6 in the Presence of Inflammatory Signaling

(2010) Brett C. DiNatale et al.   TOXICOLOGICAL SCIENCES

DNA vaccine with α-galactosylceramide at prime phase enhances anti-tumor immunity after boosting with antigen-expressing dendritic cells

(2010) Daejin Kim et al.   VACCINE

Nanoshell-Enabled Photothermal Cancer Therapy: Impending Clinical Impact

(2008) Surbhi Lal et al.   ACCOUNTS OF CHEMICAL RESEARCH

Minimally Invasive Protein Delivery with Rapidly Dissolving Polymer Microneedles

(2008) S. P. Sullivan et al.   ADVANCED MATERIALS

Virotherapy as An Approach Against Cancer Stem Cells

(2008) Camilla Ribacka et al.   CURRENT GENE THERAPY

Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients

(2008) F. S. Hodi et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

CTLA-4 Control over Foxp3+ Regulatory T Cell Function

(2008) K. Wing et al.   SCIENCE